The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
patients undergoing cardiac surgery
thrombocytopenia
oral anti-coagulant
anti platelet agents
Parallel
fresh frozen plasma
Biological/Vaccinetransfusion of fresh frozen plasma
prothrombin complex concentrate
Biological/Vaccineprothrombin complex concentrate administration
treatment time
duration from the time of diagnosing CT-EXTEM prolongation (ordering PCC or FFP) to the time achieving bleeding control (completing administration of PCC or FFP)
Red Blood Cell amount
Red Blood Cell transfusion amount during surgery
FFP amount
Red Blood Cell transfusion amount during surgery
Platelet amount
Platelet transfusion amount during surgery
cryoprecipiate amount
amount of cryoprecipitate transfusion
Thromboembolism complication
myocardial infarction, stroke, cerebral infarction, bowel ischemia
Click on the lead sponsor to view all of their trials.
Konkuk University Medical Center
Lead sponsor
Asan Medical Center
Collaborator
Soonchunhyang University Hospital
Collaborator
